What is LUNG's dilution risk score?

LUNG has a latest available DilutionScore record of 40/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for LUNG, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for LUNG?

DilutionWatch tracks 25 SEC filing types for LUNG including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect LUNG shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For LUNG, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for LUNG tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for LUNG. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

LUNG Dilution Risk Score: 40/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

40

💰 Cash Runway

40

📊 Float Risk

10

⚠️ Warrant Exposure

15

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 15%

🔄 Reverse Split model est. 30%

• 50-day avg $1.36 approaching $1 threshold

🔔 Track LUNG — Get forecast alerts →

Market Data

Market Cap$69.69M

Shares Outstanding42.95M

Float37.27M

Cash$55.84M

Debt$40.73M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 26.9% shares (2026Q1 vs prior)

114 institutional holders · 43.01M shares

#1 MORGAN STANLEY 11.77M shares

#2 PRIMECAP MANAGEMENT CO/CA/ 4.72M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 3.27M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.06M

Days to Cover1.4

% of Float2.8%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31

xbrl XBRL CONVERTIBLE 2021-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual LUNG Dilution Snapshot

Pulmonx Corporation (LUNG) has a DilutionScore of 40/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 215,291.
Recent SEC activity tracked for LUNG: xbrl on 2026-03-31; xbrl on 2021-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

More Research for LUNG

LUNG FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

LUNG — Pulmonx Corporation Dilution Risk Tracker